Las Meninas — Diego Velázquez, 1656. Museo del Prado, Madrid.

Your science is in the room

Velázquez knows that the painting was not the hard part. Deciding what to illuminate was.

Velázquez knows that the painting was not the hard part.
Deciding what to illuminate was.

Sometimes the market can’t see it.
Sometimes it can — but not the part that matters.

The Infanta

// The Product

She’s the first thing you notice. Not because she’s the most important figure here — but because she’s the most illuminated one.

In a market, what wins is not what’s most complex. Not what’s most true. What wins is what’s under the right light.

She’s the first thing you notice. Not because she’s the most important figure here — but because she’s the most illuminated one.

In a market, what wins is not what’s most complex. Not what’s most true. What wins is what’s under the right light.

The Mirror

// The Market

At the back of the painting, there is a mirror reflecting the king and queen, the most important subjects of the scene, who are barely visible in the reflection.

The product isn’t the problem. The question is which part of it the market is actually looking for.

At the back of the painting, there is a mirror reflecting the king and queen, the most important subjects of the scene, who are barely visible in the reflection.

The product isn’t the problem. The question is which part of it the market is actually looking for.

The Painter

// The Strategy

He painted himself into the scene. Brush in hand. Looking directly at you.

The one who makes things visible is part of what makes them valuable.

Commercial strategy isn’t invisible infrastructure. It’s part of how a product becomes real in the world.

He painted himself into the scene. Brush in hand. Looking directly at you.

The one who makes things visible is part of what makes them valuable.

Commercial strategy isn’t invisible infrastructure. It’s part of how a product becomes real in the world.

This is what a product looks like

when everything is
under the right light.

i'm Lola Furones

I don’t improve your product. I don’t sell you visibility.
I find the right commercial strategy to make sure
the market sees your work for what it’s actually worth.

neuroscience · Life science · Medtech

What i do

I work with life science, medtech and neuroscience companies to build their commercial foundation — value proposition, market positioning, messaging, and sales strategy. And with investment firms that need an independent expert view on the commercial potential of emerging companies.

Strong science doesn’t automatically find its market.

Strong science doesn’t
automatically find
its market.

The problem is rarely the product.
More often, it’s the clarity around what it solves, who it’s for, and why it matters now.

Services

A winning commercial strategy
doesn’t happen by accident.

FOR YOUR COMPANY

A clear picture of where your product stands, where the real unmet needs are, and what your commercial opportunity actually looks like. Your communication becomes precise enough to work — for buyers who need to understand what you do in one conversation, not five. An independent read on a company’s science, market position, and commercial logic — structured and free of conflict of interest.

MARKET ANALYSIS & POSITIONING · MESSAGING & MARKETING STRATEGY · EXPERT ASSESSMENT

FOR YOUR TEAM

Your team learns how to build sharper messaging, targeted outreach, and sales actions around real market opportunities. The focus is not on selling harder, but on identifying where the product truly fits, communicating its value credibly, and turning focused actions into measurable pipeline growth. The goal is sustained commercial progress, not sales noise or empty promises.

SALES COACHING · TEAM TRAINING

FOR MEDTECH / SCIENCE-DRIVEN INVESTMENTS

For investors considering Medtech/science-driven opportunities, I provide independent market-focused assessments that bridge scientific understanding and commercial reality. I evaluate whether an emerging technology addresses a real market need, who would adopt it, how it compares to existing solutions, and which risks may affect its path to market. My work goes beyond the company’s own pitch by combining market research, expert conversations, network-based insights and targeted strategic questions.

INVESTOR MARKET ADVISORY

The market understands what you do, the team can sell it,

and the results follow.

How I Work

scoping

We define the problem, the context, and the scope. I ask direct questions. This usually takes one or two calls.

analysis & work

Depending on the engagement, I run market analysis, develop messaging, build training materials, or review commercial strategy. The output is always something you can use.

delivery

You receive the work in a clear, structured format — with context, rationale, and concrete next steps. Built to fit your workflow, not to fill a shelf.

ongoing support

Most engagements include a review session after delivery. For ongoing work, we define the scope together and continue from there.

Who I Am

I’m a biologist with a PhD in Neuroscience, with a strong research background including work on Alzheimer’s disease at Roche. Over the past six years, I’ve worked with life science, medtech, and neurotechnology companies on positioning, messaging, sales strategy, market analysis, and go-to-market execution.

I help translate complex technologies into clear market narratives: understanding what the product does, where the market has space for it, how to explain its value, and how to reach the right audience.

The technology is usually not the problem. Knowing how to teach it, position it, and bring it to market is where most of the work actually begins.

My background combines neuroscience, research, didactics, and commercial strategy.

I’m Lola Furones

“ I don’t make your product look better than it is. I find the right angle to make its real value clear, credible, and visible to the market. ”

Your work is in the room.
Let’s make sure the market can see it.

Your work is in the room.
Let’s make sure
the market can see it.

Book a free 20-minute call. We’ll discuss your current situation,
your commercial goals, and whether my approach is the right fit.

→

I’M LOLA FURONES

Science, made visible to the market.

Handcrafted by

Why Tri-bù Hive?
The name comes from my startup on thinking patterns for human connection: discover

Tri-bù.

Why Tri-bù Hive?
The name comes from my startup on thinking patterns for human connection: discover

Las Meninas — Diego Velázquez, 1656. Museo del Prado, Madrid.

Your science is in the room

Velázquez knows that the painting was not the hard part. Deciding what to illuminate was.

Velázquez knows that the painting was not the hard part. Deciding what to illuminate was.

Velázquez knows that the painting was not the hard part.Deciding what to illuminate was.

Sometimes the market can’t see it.Sometimes it can — but not the part that matters.

Sometimes the market can’t see it.Sometimes it can — but not the part that matters.

Sometimes the market can’t see it.Sometimes it can — but not the part that matters.

The Infanta

// The Product

She’s the first thing you notice. Not because she’s the most important figure here — but because she’s the most illuminated one.

In a market, what wins is not what’s most complex. Not what’s most true. What wins is what’s under the right light.

She’s the first thing you notice. Not because she’s the most important figure here — but because she’s the most illuminated one.

In a market, what wins is not what’s most complex. Not what’s most true. What wins is what’s under the right light.

The Mirror

// The Market

At the back of the painting, there is a mirror reflecting the king and queen, the most important subjects of the scene, who are barely visible in the reflection.

The product isn’t the problem. The question is which part of it the market is actually looking for.

At the back of the painting, there is a mirror reflecting the king and queen, the most important subjects of the scene, who are barely visible in the reflection.

The product isn’t the problem. The question is which part of it the market is actually looking for.

The Painter

// The Strategy

He painted himself into the scene. Brush in hand. Looking directly at you.

The one who makes things visible is part of what makes them valuable.

Commercial strategy isn’t invisible infrastructure. It’s part of how a product becomes real in the world.

He painted himself into the scene. Brush in hand. Looking directly at you.

The one who makes things visible is part of what makes them valuable.

Commercial strategy isn’t invisible infrastructure. It’s part of how a product becomes real in the world.

This is what a product looks like

This is what a product looks like

when everything isunder the right light.

when everything isunder the right light.

when everything isunder the right light.

I don’t improve your product. I don’t sell you visibility.I find the right commercial strategy to make surethe market sees your work for what it’s actually worth.

neuroscience · Life science · Medtech

I work with life science, medtech and neuroscience companies to build their commercial foundation — value proposition, market positioning, messaging, and sales strategy. And with investment firms that need an independent expert view on the commercial potential of emerging companies.

Strong science doesn’t automatically find its market.

Strong science doesn’tautomatically findits market.

The problem is rarely the product. More often, it’s the clarity around what it solves, who it’s for, and why it matters now.

The problem is rarely the product. More often, it’s the clarity around what it solves, who it’s for, and why it matters now.

A winning commercial strategydoesn’t happen by accident.

A winning commercial strategydoesn’t happen by accident.

A winning commercial strategydoesn’t happen by accident.

The market understands what you do, the team can sell it,

and the results follow.

Tri-bù.

Tri-bù.

Velázquez knows that the painting was not the hard part.
Deciding what to illuminate was.

Sometimes the market can’t see it.
Sometimes it can — but not the part that matters.

Sometimes the market can’t see it.
Sometimes it can — but not the part that matters.

Sometimes the market can’t see it.
Sometimes it can — but not the part that matters.

when everything is
under the right light.

when everything is
under the right light.

when everything is
under the right light.

I don’t improve your product. I don’t sell you visibility.
I find the right commercial strategy to make sure
the market sees your work for what it’s actually worth.

Strong science doesn’t
automatically find
its market.

The problem is rarely the product.
More often, it’s the clarity around what it solves, who it’s for, and why it matters now.

The problem is rarely the product.
More often, it’s the clarity around what it solves, who it’s for, and why it matters now.

A winning commercial strategy
doesn’t happen by accident.

A winning commercial strategy
doesn’t happen by accident.

A winning commercial strategy
doesn’t happen by accident.